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1.1. Importance of EE/EED in developing world
Environmental enteropathy/Environmental enteric dysfunction (EE/
EED) was ﬁrstly described as “tropical enteropathy” in 1960′s, and was
deﬁned by chronic histological changes of small intestinal inﬂammation
in individuals living in tropical areas (Cook et al., 1969; Colwell et al.,
1968; Garcia, 1968). Histopathological abnormalities were character-
ized by decreased villous height, crypt hyperplasia, lymphocytic inﬁltra-
tion of the lamina propria, and increased intraepithelial lymphocytes,
which were accompanied by abnormalities in the absorptive function
of small intestine, such as xylose and vitamin B12. Since its discovery,
tropical enteropathy had not been recognized as a priority health
issue because it does not cause overt symptoms andwas seen in appar-
ently healthy individuals. However, EE/EEDhas risen in prominence as a
potential cause of growth faltering in children living in developing
countries. Also, recent studies demonstrated the association of ED/EED
with poor neurocognitive development and low vaccine efﬁcacy
(Guerrant et al., 2013; Korpe and Petri, 2012; Lunn et al., 1991, Jiang
et al., 2014), resulting in the current great concern of ED/EED in public
health of developing countries.
Although the exact pathogenesis of ED/EED and the developmental
mechanism of subsequent sequelae remain to be deﬁned, in this review
we will share the suggested etiology of ED/EED and discuss a solution
for children living in developing countries.
1.2. Search strategy and selection criteria of referenced papers in this review
Data for this Reviewwere identiﬁed by searches of PubMed, and ref-
erences from relevant articles using the search terms “environmental
enteropathy” and “environmental enteric dysfunction”. Only articles
published in English between 1960 and 2016 were included.
1.3. Etiology of EE/EED
EE/EED is hypothesized to be caused by the continuous exposure to
contaminated fecally contaminated food, water or fomites in poor sani-
tary condition. However, the etiology of EE/EED had been misunder-
stood for a while since its discovery that “tropical enteropathy” occurs
due to the locationwhere affected individuals are living, such as climate.
Geographical data comparing the intestinal permeability among asymp-
tomatic volunteers from 14 different countries showed “Tropical enter-
opathy” was present across the tropics, but absent in some tropical
areas with high socio-economical countries, such as Singapore and
Qatar (Menzies et al., 1999), which supports the idea that these abnor-
mal changes are dependent on the socio-economic status andnot on the
tropical climate. Therefore, in the present day, “tropical enteropathy” is
renamed as “Environmental enteropathy (EE)” or “Environmental en-
teric dysfunction (EED)”.
EE/EED can be acquired by a certain period of time of living in poor
sanitation and hygiene, whereas Celiac disease, showing the similarities
with EE/EED histologically, occurs among genetically susceptible indi-
viduals exposed to gluten containing foods. Early investigations of
Pakistanis and visiting residents to Pakistan showed that differences in
intestinal permeability and absorptive capacity were related to the
area of residence, not the areas of their origin (Lindenbaum, 1968;
Lindenbaum et al., 1971), whichwas later conﬁrmed by the studies per-
formed inWest Birmingham (Wood et al., 1991; Iqbal et al., 1996). One
study showed that Peace Corps volunteers moving to Pakistan from the
United States exhibited malabsorption of xylose (40% of participants)
and Vitamin B12 (48%) after 6 months of residence in Pakistan. More-
over, all participants showed abnormalities in histology of jejunal biop-
sy specimen at that time point. On the other hand, malabsorption of
xylose was present in only 3.3% of individuals working for diplomatic
and technical assistance organizations who resided in Pakistan duringthe same period as the Peace Corps group (Lindenbaum, 1968). Another
study, which investigated asymptomatic Indians and Pakistanis
who had moved to the United States, demonstrated that signiﬁcant
improvement in both xylose absorption and villus architecture occurred
with increasing periods of residence in US (Gerson et al., 1971). On the
other hand, cross sectional analysis of UK immigrants from India and
Afro-Caribbean countries showed that immigrants showed higher gut
permeability and abnormal histological ﬁndings compared to UK
born individuals although this study lacked the data of the time
from immigration to the study (Iqbal et al., 1996). These results demon-
strated that EE/EED is acquired by the close contact with unsanitary
condition, and abnormalities of EE/EED are at least partially reversible
over time.
1.4. Deﬁnition of disease and the difﬁculties in diagnosis in children
There are no clear diagnostic criteria of EE/EED. Identiﬁcation of
blunted villi and crypt hyperplasia in biopsy specimens collected by
upper gastrointestinal endoscopy might be required to support the di-
agnosis of EE/EED. However, these histological changes, despite the var-
ious extents in each individual, are seen in almost all people living in
unsanitary conditions in developing countries (Campbell et al., 2003b;
Lindenbaum et al., 1966), whereas extent of physical ormental poor de-
velopment varies widely. Considered together, the presence of abnor-
malities in biopsy may not be a predictor of poor outcomes from EE/
EED, such as growth faltering, oral vaccine failure and poor
neurocognitive development. Furthermore, poor growth is often evi-
dent within 1–2 years of life and is largely irreversible (Black et al.,
2008). It is also known that undernutrition (lower height and weight)
at 2 years is associated with lower human capital, represented by
shorter adult height, less schooling, reduced economic productivity,
and offspring birth weight from the analysis of multiple prospective co-
hort (Victora et al., 2008). Diagnosis of ED/EED should bemade before at
least 2 years of age. However, it is too invasive to perform biopsy by
upper gastrointestinal endoscopy of young children (b2 year-old).
These results suggest that simple, noninvasive and low-cost method
should be developed for the diagnosis of ED/EED in developing
countries.
Urinary lactulose to mannitol (L:M) ratio is the most commonly used
noninvasive method for the diagnosis of EE/EED in previous studies
(Keusch et al., 2013; Denno et al., 2014). In one study, it was shown
that L:M ratio is well correlated with histopathological change
(intraepithelial cell lymphocyte number) (Campbell et al., 2003b). How-
ever, L:M ratio is not standardized among studies. Also, it is technically
complicated for infants because fasting before testing and up to ﬁve
hour collection of urine are required. Shorter duration of urine collection
might induce insufﬁcient sampling due to involuntary micturition of in-
fants. On the other hand, longer duration can be associated with test fail-
ure of bagged urine collections (Denno et al., 2014).
Biomarkers using stool or blood samples are less invasive diagnostic
methods, and previous studies have shown their usefulness for the diag-
nosis of EE/EED (Wang et al., 2000; Mondal et al., 2012; Donowitz et al.,
2016; George et al., 2015; Benzoni et al., 2015; Lin et al., 2013). Recently,
Naylor et al. assessed 22 biomarkers of EE/EED by stool or blood from
700 newborn infants who are participants of the PROVIDE (Perfor-
mance of Rotavirus and Oral vaccines in Developing Countries) study
in Bangladesh (Naylor et al., 2015). This study showed that combina-
tions of these biomarkers are useful for the prediction of future growth
faltering or oral vaccine low efﬁcacy. They also showed the difﬁculty to
determine a single marker for the diagnosis of ED/EED because of its
complexity in pathogenesis.
As described later, EE/EED is not a simple pathological condition of the
increased gut permeability by the morphological changes of the gut, but
consists of multiple abnormalities, including enteric and systemic inﬂam-
mations and subsequentmetabolic changes. Thus,we should take into ac-
count the disease complexity at the diagnosis of EE/EED.
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The hypothesized pathogenesis of EE/EED is shown in Fig. 1. People
living in poor sanitary conditions are continuously exposed to intestinal
bacteria, viruses and parasites by ingestion of food and water contami-
nated with feces. Ingested bacteria may stimulate the small intestine,
resulting in the chronic gut inﬂammation accompanied by morpholog-
ical changes, such as ﬂattened villi and crypt hyperplasia. Subsequent
increased gut permeability, caused by chronic inﬂammation and mor-
phological changes in small intestine, induces bacterial translocation
followed by systemic inﬂammation andmetabolic changes. Malabsorp-
tion, which might be explained by ﬂattened villi, is often accompanied
with morphological changes of small intestine (Kelly et al., 2016),
resulting in the malnutrition. It is assumed that these abnormalities
are overlapping but not equitably occurring in each case.We have to re-
alize which abnormality is present in each individual in order to design
effective interventions.
2.1. Impact of continuous exposure to feces on gut microbiome in the small
intestine
Although it is likely that continuous exposure to bacteria from feces
in upper gastrointestinal tract is themain cause of EE/EED, based on ep-
idemiological studies, it is still unclear how these enteropathogens trig-
ger the development of EE/EED.
Small intestine bacterial overgrowth (SIBO) is a subclinical quantita-
tive abnormality of bacteria in the upper gastrointestinal tract deﬁned
by greater than 105 CFU/mL upper intestinal aspirate as assessed by
both anaerobic and aerobic cultures (O'mahony and Shanahan, 2010).
Although SIBO is observed among patients with anatomic abnormalitiesFig. 1. Pathogenesis of EE/EED and long-lasting consequences. Continuous exposure to feces
seen systemically as well as locally in small intestine (black arrows). Pathogenic conditions hav
These consequences, in turn, contribute a vicious cycle (blue arrows). Abbreviations, EE, env
bacterial overgrowth.(adhesions after surgery or radiation), inﬂammation (inﬂammatory
bowel diseases and HIV infection), and metabolic disorders (diabetes
mellitus), it is frequently seen in people living in developing countries
(Donowitz and Petri, 2015). Importantly, it was also shown that SIBO
is associated with growth faltering. An earlier study in Myanmar
performing breath hydrogen test after rice meal as a diagnosis of SIBO
on 256 village children showed 20.7% of the participants had SIBO and
children having SIBO had a high relative risk of having faltered growth
(Khin Maung et al., 1992). Donowitz et al. performed glucose hydrogen
breath testing for 90 Bangladesh 2-year-old children, and showed a
strong association between the presence of SIBO and higher intestinal
inﬂammation markers (fecal REG1beta and fecal calprotectin). They
also showed the presence of SIBO is negatively correlated with growth
rate from birth to 2 year of age (delta length for age Z score from birth
to 2 years of age) (Donowitz et al., 2016). However, in this study, intes-
tinal permeability and systemic inﬂammation,which are usually elevat-
ed in patients with EE/EED, were not associated with the presence of
SIBO. These results suggested SIBO partially plays an important role in
development of EE/EED.
On the other hand, continuous exposure to fecal material may in-
duce qualitative (compositional) changes of gut microbiota. One report
from Bangladesh cohort demonstrated the association between large
intestinal microbiota assessed by monthly collected stool samples and
severe acute malnutrition. In this study, gut microbiota maturity was
measured by “relative microbiota maturity index” and “microbiota-
for-age Z-score”whichwere calculated from the child's fecalmicrobiota
relative to healthy children of similar chronologic age. Gut microbiota
immaturity correlated with growth faltering as well as malnutrition
(Subramanian et al., 2014). On the other hand, previous studies on Celi-
ac disease have shown the association between compositional changestriggers EE/EED in individuals living in poor sanitary condition. Pathogenic conditions are
e adverse effects on children's health as inducing long-lasting consequences (red arrows).
ironmental enteropathy; EED, environmental enteric dysfunction; SIBO, small intestine
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treatment in celiac disease (Wacklin et al., 2013, 2014; Sanchez et al.,
2013). One of these studies showed that the patients who are resistant
to a long-term gluten-free diet (GFD) with persistent symptoms from
celiac disease had a higher relative abundance of Proteobacteria and a
lower abundance of Bacteroides and Firmicutes compared to patients
without symptoms by GFD (Wacklin et al., 2014). Considered together,
it is suggested that not only quantitative abnormalities represented by
SIBO but also qualitative (compositional) changes of microbiota in the
small intestine play an important role in the development of EE/EED.
Further studies will be required for the comprehensive understanding
of the effect of bacterial exposure on the development of EE/EED (El
Aidy et al., 2015).
2.2. Chronic immune activation in the gut
Chronic exposure to contaminated food, water and household envi-
ronment with feces induces an inﬂammatory response that may be
asymptomatic. There is one studywhichperformed comprehensivehisto-
pathological analyses in Gambia. In this study, histopathological examina-
tions of duodenal biopsy specimens including immunohistochemical
staining were applied to 38 rural Gambian children (0.5–3 years). These
childrenhad a range of nutritional and clinical status,withmedianweight
z score was−4.6 and 75% with diarrhea. They compared these ﬁndings
with 19 age matched UK controls. All Gambian children had the ﬁndings
of EE/EEDbyhistopathology. Althoughmorphological changeswere inde-
pendent of nutritional status, T cell numbers rose and B cell numbers in
the gut fell with worsening nutrition. They have also shown that the
ratio of regulatory cytokines (TGF-β plus IL-10) over inﬂammatory cyto-
kines (IFN-γ plus TNF-α) was decreased in malnourished children com-
pared to well-nourished children (Campbell et al., 2003b). This study
indicated that chronic T cell mediated inﬂammatory responses are in-
duced during EE/EED. Recent work using a novel RNA selective isolation
procedure from human feces, coupled with high-density whole human
transcriptome microarray technology also supported the chronic gut in-
ﬂammations by T cells in children with EE/EED (Yu et al., 2016).
2.3. Bacterial translocation
High permeability of the gut induces bacterial translocation into
blood. In the study of rural Gambian infants between 8 and 64 weeks of
age, plasma concentrations of endotoxin were elevated and related to
both growth faltering and measures of mucosal enteropathy in histopa-
thology. This study also demonstrated that immunoglobulin-G-endotoxin
core antibodywas negatively correlatedwith height growth (cm/month)
and positively correlated with gut permeability (L:M ratio) (Campbell et
al., 2003a). These results indicate that increased gut permeability induces
translocation of bacterial components into blood and induces immune
stimulation, resulting in growth faltering. Recently, in a murine model,
it was reported that the gut vascular barrier (GVB), which controls the
translocation of antigens into the bloodstream and prohibits entry of
the microbiota, can be disrupted by some pathogenic bacteria. In this
study, GVBwas disrupted directly by Salmonella. Also, they demonstrated
that the GVD is modiﬁed in Celiac disease patients with elevated serum
transaminases probably due to bacterial translocation induced by
disrupted gut barrier function (Spadoni et al., 2015). These results sug-
gested that bacterial translocation can be enhanced in a vicious cycle by
the disruption of gut barrier and by the exposure to pathogenic bacteria.
3. Health problems in developing countries: Long-lasting conse-
quences by EE/EED
3.1. Malnutrition and growth faltering
Although strategies of breastfeeding promotion for mother and pro-
viding sufﬁcient food for children have a large effect on survival, theireffect on stunting is small (Dewey and Adu-Afarwuah, 2008; Bhutta et
al., 2008; Fekadu et al., 2015; Alemayehu et al., 2015; Yisak et al.,
2015; Asfaw et al., 2015). For all developing countries, it is estimated
that 32% and 20% of children (b5 years old) are under-height (height-
for-age Z score b −2) and under-weight (weight-for-age Z
score b−2) for age (Black et al., 2008). The frequency of enteric infec-
tions (diarrheal episodes or positivity of pathogenic gut organisms) in
early childhood is proven to be a risk factor of growth faltering (Assis
et al., 2005; Black et al., 1984, 2008; Checkley et al., 2003; Molbak et
al., 1997, Valentiner-Branth et al., 2001; Checkley et al., 1998). Further-
more, it was shown in Gambian cohort in 1991 that the persistent in-
creased gut permeability between 2 and 15 months of age was
correlated with growth faltering, regardless of diarrheal episodes
(Lunn et al., 1991). These results help us to arrive at the awareness
that not only sufﬁcient food and adequate breast feeding but also pre-
vention for chronic gut inﬂammation by EE/EED are essential to achieve
expected growth in children living in developing world. Furthermore,
linear growth faltering occurs within the ﬁrst two years of life, and it
is irreversible (Black et al., 2008). Considered together, it is necessary
to diagnose EE/EED as early as possible in their life.
3.2. Vaccine failure (changes in gut immune responses and systemic
inﬂammation)
It has been shown thatmanyoral vaccines, both live andnon-living, are
less immunogenic and less protectivewhen administered to individuals in
developing countries than those in developed countries (Qadri et al.,
2013). The PROVIDE study used several makers of systemic inﬂammation
and gut inﬂammation early in life, and tested the relation between these
markers and vaccine efﬁcacy. Gut inﬂammation and systemic inﬂamma-
tion were closely related to oral vaccine underperformance whereas sys-
temic inﬂammation was positively associated with better parenteral
vaccine responses (Naylor et al., 2015). This result emphasized that low
efﬁcacy of oral vaccine in developing countries are, at least partially, due
to chronic gut and systemic inﬂammation. On the other hand, recent
clinical trials of oral polio vaccine efﬁcacy after antibiotic treatment could
not demonstrate better OPV efﬁcacy although gut inﬂammation was im-
proved by the antibiotics. In this study, vaccine efﬁcacy (seroconversion)
was negatively correlated with the presence of viral pathogens in stool,
especially enteroviruses, adenoviruses and wild rotaviruses (Grassly et al.,
2016). This study suggested that direct viral interference of viral pathogens
with innate antiviral immune mechanisms is another possible explanation
of the poor immunogenicity of oral polio vaccine in children in developing
countries.
3.3. Neurocognitive development failure
It was shown that enteric parasite infections, such as Giardia
(Berkman et al., 2002) and Cryptosporidium (Guerrant et al., 1999),
and diarrheal episodes as well as stunting during early life are associat-
ed with poor neurocognitive development in later life (Berkman et al.,
2002; Niehaus et al., 2002; Guerrant et al., 1999; Mendez and Adair,
1999). Also animal models have shown that a perinatal inﬂammatory
state has an adverse effect on neurocognitive development (Boksa,
2010; Dinel et al., 2014; Bland et al., 2010; Spencer et al., 2011). System-
ic inﬂammation induced by intravenous administration of lipopolysac-
charide (LPS) in early life (14 days after birth) altered emotional
behavior at adolescence (30 days after birth) and adulthood (90 days
after birth) in the murine model. In this study, decreased phosphoryla-
tion of the glucocorticoid receptor in the prefrontal cortex of brain was
shown in mice treated with LPS (Dinel et al., 2014). These studies
suggest that systemic inﬂammation results in subsequent poor
neurocognitive development.
Other than systemic inﬂammation induced by bacterial transloca-
tion, alteration of iron metabolism is an additional possible explanation
for poor neurocognitive development from EE/EED. EE/EED has an
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of iron homeostasis. Chronic systemic inﬂammation induces hepcidin
release from liver (Silva and Faustino, 2015). Hepcidin acts to block
iron efﬂux from various cell types by binding to the iron transfer
ferroportin (Fpn), and down regulating its expression (Tussing-
Humphreys et al., 2012). Hepcidin ﬁnally induces the accumulation of
iron in various cells including neurons, astrocytes and microglia in
CNS, resulting in accumulation of intracellular iron and lack of iron
availability for important development processes, such as myelination,
monoamine synthesis, neuronal metabolic activities and the proper de-
velopment of neuronal morphology (Oria et al., 2016; Urrutia et al.,
2013; Murray-Kolb, 2013). Although plasma iron levels are often de-
creased in children with EE/EED, iron supplementation is complicated
by low efﬁcacy in developing countries and can result in a more proin-
ﬂammatory state in the intestinal tract, as intestinal iron enhances bac-
terial proliferation (Jaeggi et al., 2015).
In addition, changes of gut microbiota might be related to
neurocognitive disorder. Late-onset autism has been associated with
abnormal gut microbiota (Finegold et al., 2002). Microbiota regulation
of gut derived 5-HT by affecting biosynthesis of enterochromafﬁn cells
may affect neurodevelopment (Yano et al., 2015). Furthermore, some in
vivo experiments suggested that microbiota metabolites enhance the
production of several neurotransmitters, such as gamma-aminobutyric
acid and catecholamine from intestinal epithelial cells (Barrett et al.,
2012, Asano et al., 2012). Microbiota-mediated changes in blood brain
barrier (BBB) permeability were associated with reduced expression of
the tight junction proteins occludin and claudin-5, which regulate barrier
function in endothelial tissues (Braniste et al., 2014). Although evidence is
only now emerging for the association of EE/EED with cognitive impair-
ment in human (Jiang et al., 2014), it is a possible part of the explanation
for the impairedneurocognitive development of children living inpoverty
(Oria et al., 2016).
3.4. Mother's stunting results in physical and mental development of next
generation
It has been known that Intrauterine Growth Restriction is more fre-
quently seen in the children of mothers with malnutrition. Also, it was
reported that maternal malnutrition assessed by BMI b 18.5 kg/m2,
height or weight was associated with growth faltering in their children
(Mondal et al., 2012; Naylor et al., 2015). An additional maternal contri-
bution may be prenatal infection during pregnancy which causes
neurocognitive development failure in a murine model (Boksa, 2010).
Moreover, it was shown that epigenetic changes inﬂuenced by nutrient
intake can be passed frommother to infant. Seasonal differences in diet
and DNA methylation in people living in rural Gambia showed that
maternal nutritional status during early pregnancy caused persistent
epigenetic changes at human metastable epialleles (Dominguez-Salas
et al., 2014). Considered together, the mother's nutritional status and
health is an important determinant of physical and neurocognitive
development in children, suggesting that interventions targetingmater-
nal health should be considered for preventing health problems in
children.
4. Challenges to understand and prevent EE/EED
4.1. Efforts for more understanding of the complex pathogenesis of ED/EED
As described above, EE/EED is complex pathogenic state in which
multiple organs, including the small intestine, systemic circulation,
liver and brain, are involved sequentially. Although dysfunctions of
these organs overlap, the degree of dysfunction may vary among indi-
viduals. Moreover, determinant factors of sequelae such as physical
and neurocognitive growth faltering and oral vaccine inefﬁcacy, are
still undeﬁned. Naylor et al. applied clustering analysis to socioeconom-
ic data, physiological data, andbiomarkersmeasured by blood andurinefrom Bangladesh children. They demonstrated 3 major clusters by this
analysis (Fig. 2). Cluster 1 included days of diarrhea andwas dominated
by systemic inﬂammation biomarkers. Cluster 2 contained enteric in-
ﬂammation and micronutrients. Cluster 3 comprised maternal health
markers. They compared the association between each cluster and
long-lasting consequences (child growth rate and vaccine efﬁcacy). In
this study, each clusterwas independently associatedwith child growth
or vaccine efﬁcacy, which emphasized the importance of measuring the
degree of dysfunction by each involved organ (or each cluster) in order
to precisely predict the risk for later sequelae (Naylor et al., 2015).
The Etiology, Risk factors, and Interactions of Enteric Infections and
Malnutrition and the Consequences for Child Health (MAL-ED) study
is a prospective longitudinal study established at sites in 8 countries
with historically high incidence of diarrheal disease and undernutrition
(Kosek et al., 2014). This study is prospectively collecting data of
growth, vaccine response and cognitive development as well as gut mi-
crobial ecology, enteropathogen infection, and dietary intake. This mul-
tinational prospective study is expected to improve scientiﬁc
understanding of the complex relationships between ED/EED and its
long-lasting consequences.
Research on predisposing host factors is also important for
developing effective interventions although EE/EED as its name
implies may have a predominantly non-genetic pathogenesis.
Apolipoprotein E4 (APOE4) is the gene related to cholesterol trans-
port and metabolism. Studies on children living in poor sanitation
in Brazil demonstrated that children who having APOE4 have
improved cognitive development after heavy diarrheal episodes
compared to APOE4 negative children (Oria et al., 2005, 2010),
suggesting the existence of a protective host genetic factor against
neurocognitive poor development by ED/EED. Further investigation
on protective host factors should be encouraged to identify the
new diagnostic or treatment strategy.
Other than cohort analyses, we should make efforts for revealing
pathogenesis of EE/EED by in vivo or in vitro experiment. Kelly et al.
demonstrated bacterial translocation in patients with EE/EED using
confocal laser endomicroscopy (CLE) which is a new technique for
the real-time visualization and quantiﬁcation of intestinal epithelial
barrier integrity. They showed cell shedding events, which represent
epithelial cell defects assessed by CLE, are positively correlated with
plasma LPS concentration (Kelly et al., 2016). Yu et al. reported a
novel technique extracting host messenger RNA from stool samples.
They collected samples from 259 rural Malawian children with
varying states of EE/EED, and identiﬁed 12 transcripts associated
with the severity of EE/EED, including chemokines that stimulate
T-cell proliferation, Fc fragments of multiple immunoglobulin
families, interferon-induced mediators that dampen cellular
responses to hormones (Yu et al., 2016). These new technologies
are expected to further reveal the potential mechanisms of gut
damage followed by bacterial translocation in human.
There are some studies using malnourished mice produced by low-
protein diet (Clough et al., 2016; Hickman et al., 2014). Maier et al.
sought to assess the oral vaccine efﬁcacy amongmurine protein-energy
malnutrition (PEM) model. In this study, PEM mice were produced by
the administration of isocaloric multideﬁcient regional basic diet
which consists of 5% fat, 7% protein, and 88% carbohydrate. PEM mice
showedmalnutrition (reducedweight gain) by 3weeks of age although
they could not demonstrate impaired rotavirus vaccine efﬁcacy in these
mice (Maier et al., 2013). Also, Brown et al. established amurine EE/EED
model treated by early-life consumption of a moderately malnourished
diet, in combination with iterative oral exposure to commensal
Bacteroidales species and Escherichia coli. Murine EE/EEDmodel had sim-
ilar features of human EE/EED, which showed villous blunting in histo-
pathology, higher intestinal permeability, chronic gut inﬂammation,
and subsequent growth faltering (Brown et al., 2015). These novel mu-
rine models are expected to add to the understanding of the pathogen-
esis of ED/EED.
Fig. 2. Cluster dendrogram of biomarkers of EE/EED. This hierarchical analysis of biomarkers can accommodate a mixture of quantitative and qualitative variables and classify those
strongly correlated or similar biomarkers into the same clusters using homogeneity criterion. Adjacent markers are the most closely correlated, while increased distance indicates
decreasing correlations. Biological samples (blood or urine) were collected at 6, 12 and/or 18 weeks of age in the PROVIDE study. Cytokines were collected at 18 weeks of age, and
analyzed as the association of 50–75th percentile as (2), and 75–100th percentile as (3). Biomarkers were well differentiated by the 3 major clusters, consisting cluster 1 (systemic
inﬂammation in red), cluster 2 (enteric inﬂammation and malabsorption in black) and cluster 3 (maternal health in green). Adapted from the paper by Naylor et al. (Naylor et al.,
2015). Abbreviations, IL, interleukin; TNF, Tissue necrosis factor; MIP, macrophage inﬂammatory protein; CRP, C-reactive protein; sCD, soluble cluster of differentiation; MPO,
myeloperoxidase; Reg, regenerating islet derived protein; RBP, retinol binding protein; HAZ, height-for-age Z-score; WAZ, weight-for-age Z-score; WHZ, weight-for-height Z score.
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Strategies to prevent or treat enteropathogen infections in the gut
are one logical approach, although there are no reports which showed
favorable outcomes currently. One study assessing seven days treat-
mentwith Rifaximin,which is a nonabsorbable and broad-spectruman-
tibiotic, for children in Malawi did not show an improvement of L:M
ratio compared with placebo at 21 days after ﬁnishing Rifaximin treat-
ment (Trehan et al., 2009). Azithromycin also did not improve the im-
munogenicity of oral poliovirus vaccine. In this study, oral 10 mg/kg
azithromycin or placebo once dailywas given for 3 days, followed by se-
rotype-3 monovalent oral polio vaccine on day 14. However, fecal bio-
markers of EE/EED (calprotectin, myeloperoxidase, alpha1-
antitrypsin) were reduced in the azithromycin group (Grassly et al.,
2016), suggesting that it might need a certain amount of time for recov-
ery of gut immunity from the treatment of EE/EED by antibiotic.
A probiotic trial for 30 days had no effect on L:M ratio of 3–5 years
old Malawian children (Galpin et al., 2005). Also, probiotics and prebi-
otics for severe acute malnutrition (PRONUT study) did not have an im-
pact on the improvement of malnutrition (Kerac et al., 2009).
Other than bacterial targeted strategies, anti-inﬂammatory agents,
which are used for inﬂammatory bowel diseases or Celiac disease, are
potential candidates for treatment of EE/EED (Petri et al., 2014). There
is one randomized control trial performed in Nairobi, usingMesalazine.
The mechanism of action of Mesalazine is blocking transcription of in-
ﬂammatory cytokines in colonic epithelial cells (Nielsen and Munck,
2007) which is approved to use for inﬂammatory bowel diseases
(IBD) patients (Jones et al., 2014). In this study, there were no signiﬁ-
cant differences between the mesalazine and placebo groups in linear
growth rate or change in height-for-age z-score after 56 days of study
period, which consisted of 28 days treatment followed by 28 days of
drug-free period, although primary objective of this study was investi-
gating the safety of mesalazine for children with severe acute malnutri-
tion (SAM). The work of Naylor et al. suggests merit in interventions toimprovematernal health and reduce stunting and under-weight at birth
to prevent EE/EED (Naylor et al., 2015).
5. Conclusions
EE/EED has a great impact on public health in developing countries
due to its contribution to poor physical and mental development, and
oral vaccine under-performance. Current research has enhanced our
understanding of the pathogenesis of EE/EED. In the near future, murine
model and new technologieswill give us additional insight into its path-
ogenesis. Non-invasive and cost-effective diagnostic methodswhich ac-
curately predict the risk of long-lasting poor consequences of EE/EED
will be one part of this response. Efforts to improve maternal health
and sanitation offer hope for prevention. Understanding EE/EED offers
real hope for interventions to allow children in developing world to
achieve their full potential.
Acknowledgements
Work from the authors' laboratories was supported by the Research
Program on Emerging and Re-emerging Infectious Diseases from Japan
Agency forMedical Research and Development (AMED), a Grant for Na-
tional Center for Global Health and Medicine (28-1102), NIH grant R01
AI-43596 and by the Bill & Melinda Gates Foundation (OPP1017093).
References
Alemayehu, M., Tinsae, F., Haileslassie, K., Seid, O., Gebregziabher, G., Yebyo, H., 2015. Un-
dernutrition status and associated factors in under-5 children, in Tigray, Northern
Ethiopia. Nutrition 31, 964–970. http://dx.doi.org/10.1016/j.nut.2015.01.013.
Asano, Y., Hiramoto, T., Nishino, R., Aiba, Y., Kimura, T., Yoshihara, K., Koga, Y., Sudo, N.,
2012. Critical role of gut microbiota in the production of biologically active, free cat-
echolamines in the gut lumen of mice. Am. J. Physiol. Gastrointest. Liver Physiol. 303,
G1288–G1295. http://dx.doi.org/10.1152/ajpgi.00341.2012.
Asfaw, M., Wondaferash, M., Taha, M., Dube, L., 2015. Prevalence of undernutrition and
associated factors among children aged between six to ﬁfty nine months in Bule
31K. Watanabe, W.A. Petri Jr / EBioMedicine 10 (2016) 25–32Hora district, South Ethiopia. BMC Public Health 15, 41. http://dx.doi.org/10.1186/
s12889-015-1370-9.
Assis, A.M., Barreto, M.L., Santos, L.M., Fiaccone, R., Da Silva Gomes, G.S., 2005. Growth fal-
tering in childhood related to diarrhea: a longitudinal community based study. Eur.
J. Clin. Nutr. 59, 1317–1323.
Barrett, E., Ross, R.P., O'Toole, P.W., Fitzgerald, G.F., Stanton, C., 2012. Gamma-
aminobutyric acid production by culturable bacteria from the human intestine.
J. Appl. Microbiol. 113, 411–417. http://dx.doi.org/10.1111/j.1365-2672.2012.05344.x.
Benzoni, N., Korpe, P., Thakwalakwa, C., Maleta, K., Stephenson, K., Manary, M., Manary,
M., 2015. Plasma endotoxin core antibody concentration and linear growth are unre-
lated in rural Malawian children aged 2–5 years. BMC Res. Notes 8, 258. http://dx.doi.
org/10.1186/s13104-015-1238-1.
Berkman, D.S., Lescano, A.G., Gilman, R.H., Lopez, S.L., Black, M.M., 2002. Effects of
stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in
late childhood: a follow-up study. Lancet 359, 564–571.
Bhutta, Z.A., Ahmed, T., Black, R.E., Cousens, S., Dewey, K., Giugliani, E., Haider, B.A.,
Kirkwood, B., Morris, S.S., Sachdev, H.P., Shekar, M., Maternal & Child
Undernutrition Study, G., 2008. What works? Interventions for maternal and child
undernutrition and survival. Lancet 371, 417–440. http://dx.doi.org/10.1016/S0140-
6736(07)61693-6.
Black, R.E., Brown, K.H., Becker, S., 1984. Effects of diarrhea associated with speciﬁc
enteropathogens on the growth of children in rural Bangladesh. Pediatrics 73,
799–805.
Black, R.E., Allen, L.H., Bhutta, Z.A., Caulﬁeld, L.E., De Onis, M., Ezzati, M., Mathers, C.,
Rivera, J., Maternal & Child Undernutrition Study, G., 2008. Maternal and child under-
nutrition: global and regional exposures and health consequences. Lancet 371,
243–260. http://dx.doi.org/10.1016/S0140-6736(07)61690-0.
Bland, S.T., Beckley, J.T., Young, S., Tsang, V., Watkins, L.R., Maier, S.F., Bilbo, S.D., 2010. En-
during consequences of early-life infection on glial and neural cell genesis within
cognitive regions of the brain. Brain Behav. Immun. 24, 329–338. http://dx.doi.org/
10.1016/j.bbi.2009.09.012.
Boksa, P., 2010. Effects of prenatal infection on brain development and behavior: a review
of ﬁndings from animal models. Brain Behav. Immun. 24, 881–897. http://dx.doi.org/
10.1016/j.bbi.2010.03.005.
Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Toth, M., Korecka, A.,
Bakocevic, N., Ng, L.G., Kundu, P., Gulyas, B., Halldin, C., Hultenby, K., Nilsson, H.,
Hebert, H., Volpe, B.T., Diamond, B., Pettersson, S., 2014. The gutmicrobiota inﬂuences
blood-brain barrier permeability in mice. Sci. Transl. Med. 6, 263ra158. http://dx.doi.
org/10.1126/scitranslmed.3009759.
Brown, E.M., Wlodarska, M., Willing, B.P., Vonaesch, P., Han, J., Reynolds, L.A., Arrieta,
M.C., Uhrig, M., Scholz, R., Partida, O., Borchers, C.H., Sansonetti, P.J., Finlay, B.B.,
2015. Diet and speciﬁc microbial exposure trigger features of environmental en-
teropathy in a novel murine model. Nat. Commun. 6, 7806. http://dx.doi.org/10.
1038/ncomms8806.
Campbell, D.I., Elia, M., Lunn, P.G., 2003a. Growth faltering in rural Gambian infants is as-
sociated with impaired small intestinal barrier function, leading to endotoxemia and
systemic inﬂammation. J. Nutr. 133, 1332–1338.
Campbell, D.I., Murch, S.H., Elia, M., Sullivan, P.B., Sanyang, M.S., Jobarteh, B., Lunn, P.G.,
2003b. Chronic T cell-mediated enteropathy in rural west African children: relation-
ship with nutritional status and small bowel function. Pediatr. Res. 54, 306–311.
Checkley, W., Epstein, L.D., Gilman, R.H., Black, R.E., Cabrera, L., Sterling, C.R., 1998. Effects
of Cryptosporidium parvum infection in Peruvian children: growth faltering and sub-
sequent catch-up growth. Am. J. Epidemiol. 148, 497–506.
Checkley, W., Epstein, L.D., Gilman, R.H., Cabrera, L., Black, R.E., 2003. Effects of acute diar-
rhea on linear growth in Peruvian children. Am. J. Epidemiol. 157, 166–175.
Clough, D., Prykhodko, O., Raberg, L., 2016. Effects of protein malnutrition on tolerance to
helminth infection. Biol. Lett. 12. http://dx.doi.org/10.1098/rsbl.2016.0189.
Colwell, E.J., Welsh, J.D., Legters, L.J., Proctor, R.F., 1968. Jejunal morphological characteris-
tics in South Vietnamese residents. JAMA 206, 2273–2276.
Cook, G.C., Kajubi, S.K., Lee, F.D., 1969. Jejunal morphology of the African in Uganda.
J. Pathol. 98, 157–169.
Denno, D.M., Vanbuskirk, K., Nelson, Z.C., Musser, C.A., Hay Burgess, D.C., Tarr, P.I., 2014.
Use of the lactulose to mannitol ratio to evaluate childhood environmental enteric
dysfunction: a systematic review. Clin. Infect. Dis. 59 (Suppl. 4), S213–S219. http://
dx.doi.org/10.1093/cid/ciu541.
Dewey, K.G., Adu-Afarwuah, S., 2008. Systematic review of the efﬁcacy and effectiveness
of complementary feeding interventions in developing countries. Matern. Child Nutr.
4 (Suppl. 1), 24–85. http://dx.doi.org/10.1111/j.1740-8709.2007.00124.x.
Dinel, A.L., Joffre, C., Triﬁlieff, P., Aubert, A., Foury, A., Le Ruyet, P., Laye, S., 2014. In-
ﬂammation early in life is a vulnerability factor for emotional behavior at adoles-
cence and for lipopolysaccharide-induced spatial memory and neurogenesis
alteration at adulthood. J. Neuroinﬂammation 11, 155. http://dx.doi.org/10.
1186/s12974-014-0155-x.
Dominguez-Salas, P., Moore, S.E., Baker, M.S., Bergen, A.W., Cox, S.E., Dyer, R.A., Fulford,
A.J., Guan, Y., Laritsky, E., Silver, M.J., Swan, G.E., Zeisel, S.H., Innis, S.M., Waterland,
R.A., Prentice, A.M., Hennig, B.J., 2014. Maternal nutrition at conception modulates
DNA methylation of human metastable epialleles. Nat. Commun. 5, 3746. http://dx.
doi.org/10.1038/ncomms4746.
Donowitz, J.R., Petri JR., W.A., 2015. Pediatric small intestine bacterial overgrowth in low-
income countries. Trends Mol. Med. 21, 6–15. http://dx.doi.org/10.1016/j.molmed.
2014.11.001.
Donowitz, J.R., Haque, R., Kirkpatrick, B.D., Alam, M., Lu, M., Kabir, M., Kakon, S.H., Islam,
B.Z., Afreen, S., Musa, A., Khan, S.S., Colgate, E.R., Carmolli, M.P., Ma, J.Z., Petri JR.,
W.A., 2016. Small intestine bacterial overgrowth and environmental enteropathy in
Bangladeshi children. mBio 7, e02102–e02115. http://dx.doi.org/10.1128/mBio.
02102-15.El Aidy, S., Van Den Bogert, B., Kleerebezem, M., 2015. The small intestine microbiota, nu-
tritional modulation and relevance for health. Curr. Opin. Biotechnol. 32, 14–20.
http://dx.doi.org/10.1016/j.copbio.2014.09.005.
Fekadu, Y., Mesﬁn, A., Haile, D., Stoecker, B.J., 2015. Factors associatedwith nutritional sta-
tus of infants and young children in Somali Region, Ethiopia: a cross- sectional study.
BMC Public Health 15, 846. http://dx.doi.org/10.1186/s12889-015-2190-7.
Finegold, S.M., Molitoris, D., Song, Y., Liu, C., Vaisanen, M.L., Bolte, E., Mcteague, M.,
Sandler, R., Wexler, H., Marlowe, E.M., Collins, M.D., Lawson, P.A., Summanen, P.,
Baysallar, M., Tomzynski, T.J., Read, E., Johnson, E., Rolfe, R., Nasir, P., Shah, H.,
Haake, D.A., Manning, P., Kaul, A., 2002. Gastrointestinal microﬂora studies in late-
onset autism. Clin. Infect. Dis. 35, S6–S16.
Galpin, L., Manary, M.J., Fleming, K., Ou, C.N., Ashorn, P., Shulman, R.J., 2005. Effect of Lac-
tobacillus GG on intestinal integrity in Malawian children at risk of tropical enterop-
athy. Am. J. Clin. Nutr. 82, 1040–1045.
Garcia, S., 1968. Malabsorption and malnutrition in Mexico. Am. J. Clin. Nutr. 21,
1066–1076.
George, C.M., Oldja, L., Biswas, S., Perin, J., Lee, G.O., Kosek, M., Sack, R.B., Ahmed, S., Haque,
R., Parvin, T., Azmi, I.J., Bhuyian, S.I., Talukder, K.A., Mohammad, S., Faruque, A.G.,
2015. Geophagy is associated with environmental enteropathy and stunting in chil-
dren in rural Bangladesh. Am.J.Trop. Med. Hyg. 92, 1117–1124. http://dx.doi.org/10.
4269/ajtmh.14-0672.
Gerson, C.D., Kent, T.H., Saha, J.R., Siddiqi, N., Lindenbaum, J., 1971. Recovery of small-in-
testinal structure and function after residence in the tropics. II. Studies in Indians and
Pakistanis living in New York City. Ann. Intern. Med. 75, 41–48.
Grassly, N.C., Praharaj, I., Babji, S., Kaliappan, S.P., Giri, S., Venugopal, S., Parker, E.P.,
Abraham, A., Muliyil, J., Doss, S., Raman, U., Liu, J., Peter, J.V., Paranjape, M., Jeyapaul,
S., Balakumar, S., Ravikumar, J., Srinivasan, R., Bahl, S., Iturriza-Gomara, M., Uhlig,
H.H., Houpt, E.R., John, J., Kang, G., 2016. The effect of azithromycin on the immuno-
genicity of oral poliovirus vaccine: a double-blind randomised placebo-controlled
trial in seronegative Indian infants. Lancet Infect. Dis. http://dx.doi.org/10.1016/
S1473-3099(16)30023-8.
Guerrant, D.I., Moore, S.R., Lima, A.A., Patrick, P.D., Schorling, J.B., Guerrant, R.L., 1999. As-
sociation of early childhood diarrhea and cryptosporidiosis with impaired physical
ﬁtness and cognitive function four-seven years later in a poor urban community in
Northeast Brazil. Am.J.Trop. Med. Hyg. 61, 707–713.
Guerrant, R.L., Deboer, M.D., Moore, S.R., Scharf, R.J., Lima, A.A., 2013. The impoverished
gut–a triple burden of diarrhoea, stunting and chronic disease. Nat. Rev.
Gastroenterol. Hepatol. 10, 220–229. http://dx.doi.org/10.1038/nrgastro.2012.239.
Hickman, D., Jones, M.K., Zhu, S., Kirkpatrick, E., Ostrov, D.A., Wang, X., Ukhanova, M., Sun,
Y., Mai, V., Salemi, M., Karst, S.M., 2014. The effect of malnutrition on norovirus infec-
tion. mBio 5. http://dx.doi.org/10.1128/mBio.01032-13 (e01032-13).
Iqbal, T.H., Lewis, K.O., Gearty, J.C., Cooper, B.T., 1996. Small intestinal permeability to
mannitol and lactulose in the three ethnic groups resident in West Birmingham.
Gut 39, 199–203.
Jaeggi, T., Kortman, G.A., Moretti, D., Chassard, C., Holding, P., Dostal, A., Boekhorst, J.,
Timmerman, H.M., Swinkels, D.W., Tjalsma, H., Njenga, J., Mwangi, A., Kvalsvig, J.,
Lacroix, C., Zimmermann, M.B., 2015. Iron fortiﬁcation adversely affects the gut
microbiome, increases pathogen abundance and induces intestinal inﬂammation in
Kenyan infants. Gut 64, 731–742. http://dx.doi.org/10.1136/gutjnl-2014-307720.
Jiang, N.M., Tofail, F., Moonah, S.N., Scharf, R.J., Taniuchi, M., Ma, J.Z., Hamadani, J.D.,
Gurley, E.S., Houpt, E.R., Azziz-Baumgartner, E., Haque, R., Petri JR., W.A., 2014. Febrile
illness and pro-inﬂammatory cytokines are associated with lower
neurodevelopmental scores in Bangladeshi infants living in poverty. BMC Pediatr.
14, 50. http://dx.doi.org/10.1186/1471-2431-14-50.
Jones, K.D., Hunten-Kirsch, B., Laving, A.M., Munyi, C.W., Ngari, M., Mikusa, J., Mulongo,
M.M., Odera, D., Nassir, H.S., Timbwa, M., Owino, M., Fegan, G., Murch, S.H.,
Sullivan, P.B., Warner, J.O., Berkley, J.A., 2014. Mesalazine in the initial management
of severely acutely malnourished children with environmental enteric dysfunction:
a pilot randomized controlled trial. BMC Med. 12, 133. http://dx.doi.org/10.1186/
s12916-014-0133-2.
Kelly, P., Besa, E., Zyambo, K., Louis-Auguste, J., Lees, J., Banda, T., Soko, R., Banda, R.,
Amadi, B., Watson, A., 2016. Endomicroscopic and transcriptomic analysis of im-
paired barrier function and malabsorption in environmental enteropathy. PLoS
Negl. Trop. Dis. 10, e0004600. http://dx.doi.org/10.1371/journal.pntd.0004600.
Kerac, M., Bunn, J., Seal, A., Thindwa, M., Tomkins, A., Sadler, K., Bahwere, P., Collins, S.,
2009. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a dou-
ble-blind efﬁcacy randomised controlled trial inMalawi. Lancet 374, 136–144. http://
dx.doi.org/10.1016/S0140-6736(09)60884-9.
Keusch, G.T., Rosenberg, I.H., Denno, D.M., Duggan, C., Guerrant, R.L., Lavery, J.V., Tarr, P.I.,
Ward, H.D., Black, R.E., Nataro, J.P., Ryan, E.T., Bhutta, Z.A., Coovadia, H., Lima, A.,
Ramakrishna, B., Zaidi, A.K., Burgess, D.C., Brewer, T., 2013. Implications of acquired
environmental enteric dysfunction for growth and stunting in infants and children
living in low- and middle-income countries. Food Nutr. Bull. 34, 357–364.
Khin Maung, U., Bolin, T.D., Duncombe, V.M., Myo, K., Nyunt Nyunt, W., Pereira, S.P.,
Linklater, J.M., 1992. Epidemiology of small bowel bacterial overgrowth and rice car-
bohydrate malabsorption in Burmese (Myanmar) village children. Am.J.Trop. Med.
Hyg. 47, 298–304.
Korpe, P.S., Petri JR., W.A., 2012. Environmental enteropathy: critical implications of a
poorly understood condition. Trends Mol. Med. 18, 328–336. http://dx.doi.org/10.
1016/j.molmed.2012.04.007.
Kosek, M., Guerrant, R.L., Kang, G., Bhutta, Z., Yori, P.P., Gratz, J., Gottlieb, M., Lang, D., Lee,
G., Haque, R., Mason, C.J., Ahmed, T., Lima, A., Petri, W.A., Houpt, E., Olortegui, M.P.,
Seidman, J.C., Mduma, E., Samie, A., Babji, S., Investigators, M.-E.N., 2014. Assessment
of environmental enteropathy in the MAL-ED cohort study: theoretical and analytic
framework. Clin. Infect. Dis. 59 (Suppl. 4), S239–S247. http://dx.doi.org/10.1093/
cid/ciu457.
32 K. Watanabe, W.A. Petri Jr / EBioMedicine 10 (2016) 25–32Lin, A., Arnold, B.F., Afreen, S., Goto, R., Huda, T.M., Haque, R., Raqib, R., Unicomb, L.,
Ahmed, T., Colford JR., J.M., Luby, S.P., 2013. Household environmental conditions
are associated with enteropathy and impaired growth in rural Bangladesh. Am.
J. Trop. Med. Hyg. 89, 130–137. http://dx.doi.org/10.4269/ajtmh.12-0629.
Lindenbaum, J., 1968. Small intestine dysfunction in Pakistanis and Americans resident in
Pakistan. Am. J. Clin. Nutr. 21, 1023–1029.
Lindenbaum, J., Alam, A.K., Kent, T.H., 1966. Subclinical small-intestinal disease in East Pa-
kistan. Br. Med. J. 2, 1616–1619.
Lindenbaum, J., Gerson, C.D., Kent, T.H., 1971. Recovery of small-intestinal structure and
function after residence in the tropics. I. Studies in Peace Corps volunteers. Ann. In-
tern. Med. 74, 218–222.
Lunn, P.G., Northrop-Clewes, C.A., Downes, R.M., 1991. Intestinal permeability, mucosal
injury, and growth faltering in Gambian infants. Lancet 338, 907–910.
Maier, E.A., Weage, K.J., Guedes, M.M., Denson, L.A., Mcneal, M.M., Bernstein, D.I., Moore,
S.R., 2013. Protein-energy malnutrition alters IgA responses to rotavirus vaccination
and infection but does not impair vaccine efﬁcacy in mice. Vaccine 32, 48–53.
http://dx.doi.org/10.1016/j.vaccine.2013.10.072.
Mendez, M.A., Adair, L.S., 1999. Severity and timing of stunting in the ﬁrst two years of life
affect performance on cognitive tests in late childhood. J. Nutr. 129, 1555–1562.
Menzies, I.S., Zuckerman, M.J., Nukajam, W.S., Somasundaram, S.G., Murphy, B., Jenkins,
A.P., Crane, R.S., Gregory, G.G., 1999. Geography of intestinal permeability and ab-
sorption. Gut 44, 483–489.
Molbak, K., Jensen, H., Ingholt, L., Aaby, P., 1997. Risk factors for diarrheal disease inci-
dence in early childhood: a community cohort study from Guinea-Bissau. Am.
J. Epidemiol. 146, 273–282.
Mondal, D., Minak, J., Alam, M., Liu, Y., Dai, J., Korpe, P., Liu, L., Haque, R., Petri JR., W.A.,
2012. Contribution of enteric infection, altered intestinal barrier function, and mater-
nal malnutrition to infant malnutrition in Bangladesh. Clin. Infect. Dis. 54, 185–192.
http://dx.doi.org/10.1093/cid/cir807.
Murray-Kolb, L.E., 2013. Iron and brain functions. Curr. Opin. Clin. Nutr. Metab. Care 16,
703–707. http://dx.doi.org/10.1097/MCO.0b013e3283653ef8.
Naylor, C., Lu, M., Haque, R., Mondal, D., Buonomo, E., Nayak, U., Mychaleckyj, J.C.,
Kirkpatrick, B., Colgate, R., Carmolli, M., Dickson, D., Van Der Klis, F., Weldon, W.,
Steven Oberste, M., Teams, P.S., Ma, J.Z., Petri JR., W.A., 2015. Environmental enterop-
athy, oral vaccine failure and growth faltering in infants in Bangladesh. EBioMedicine
2, 1759–1766. http://dx.doi.org/10.1016/j.ebiom.2015.09.036.
Niehaus, M.D., Moore, S.R., Patrick, P.D., Derr, L.L., Lorntz, B., Lima, A.A., Guerrant, R.L.,
2002. Early childhood diarrhea is associated with diminished cognitive function 4
to 7 years later in children in a northeast Brazilian shantytown. Am.J.Trop. Med.
Hyg. 66, 590–593.
Nielsen, O.H., Munck, L.K., 2007. Drug insight: aminosalicylates for the treatment of IBD.
Nat. Clin. Pract. Gastroenterol. Hepatol. 4, 160–170.
O'mahony, S., Shanahan, F., 2010. Enteric Microbiota and Small Intestinal Bacterial Over-
growth. Sleisenger and Fordrtan's Gastrointestinal and Liver Disease: Pathophysiolo-
gy/Diagnosis/Management, nineth ed., p. 1769.
Oria, R.B., Patrick, P.D., Zhang, H., Lorntz, B., De Castro Costa, C.M., Brito, G.A., Barrett, L.J.,
Lima, A.A., Guerrant, R.L., 2005. APOE4 protects the cognitive development in chil-
dren with heavy diarrhea burdens in Northeast Brazil. Pediatr. Res. 57, 310–316.
Oria, R.B., Patrick, P.D., Oria, M.O., Lorntz, B., Thompson, M.R., Azevedo, O.G., Lobo, R.N.,
Pinkerton, R.F., Guerrant, R.L., Lima, A.A., 2010. ApoE polymorphisms and diarrheal
outcomes in Brazilian shanty town children. Braz. J. Med. Biol. Res. 43, 249–256.
Oria, R.B., Murray-Kolb, L.E., Scharf, R.J., Pendergast, L.L., Lang, D.R., Kolling, G.L., Guerrant,
R.L., 2016. Early-life enteric infections: relation between chronic systemic inﬂamma-
tion and poor cognition in children. Nutr. Rev. 74, 374–386. http://dx.doi.org/10.
1093/nutrit/nuw008.
Petri JR., W.A., Naylor, C., Haque, R., 2014. Environmental enteropathy and malnutrition:
do we know enough to intervene? BMC Med. 12, 187. http://dx.doi.org/10.1186/
s12916-014-0187-1.
Qadri, F., Bhuiyan, T.R., Sack, D.A., Svennerholm, A.M., 2013. Immune responses and pro-
tection in children in developing countries induced by oral vaccines. Vaccine 31,
452–460. http://dx.doi.org/10.1016/j.vaccine.2012.11.012.
Sanchez, E., Donat, E., Ribes-Koninckx, C., Fernandez-Murga, M.L., Sanz, Y., 2013. Duode-
nal-mucosal bacteria associated with celiac disease in children. Appl. Environ.
Microbiol. 79, 5472–5479. http://dx.doi.org/10.1128/AEM.00869-13.Silva, B., Faustino, P., 2015. An overview of molecular basis of iron metabolism regulation
and the associated pathologies. Biochim. Biophys. Acta 1852, 1347–1359. http://dx.
doi.org/10.1016/j.bbadis.2015.03.011.
Spadoni, I., Zagato, E., Bertocchi, A., Paolinelli, R., Hot, E., Di Sabatino, A., Caprioli, F.,
Bottiglieri, L., Oldani, A., Viale, G., Penna, G., Dejana, E., Rescigno, M., 2015. A gut-vas-
cular barrier controls the systemic dissemination of bacteria. Science 350, 830–834.
http://dx.doi.org/10.1126/science.aad0135.
Spencer, S.J., Galic, M.A., Pittman, Q.J., 2011. Neonatal programming of innate immune
function. Am. J. Physiol. Endocrinol. Metab. 300, E11–E18. http://dx.doi.org/10.
1152/ajpendo.00516.2010.
Subramanian, S., Huq, S., Yatsunenko, T., Haque, R., Mahfuz, M., Alam, M.A., Benezra, A.,
Destefano, J., Meier, M.F., Muegge, B.D., Barratt, M.J., Vanarendonk, L.G., Zhang, Q.,
Province, M.A., Petri JR., W.A., Ahmed, T., Gordon, J.I., 2014. Persistent gut microbiota
immaturity in malnourished Bangladeshi children. Nature 510, 417–421. http://dx.
doi.org/10.1038/nature13421.
Trehan, I., Shulman, R.J., Ou, C.N., Maleta, K., Manary, M.J., 2009. A randomized, double-
blind, placebo-controlled trial of rifaximin, a nonabsorbable antibiotic, in the treat-
ment of tropical enteropathy. Am. J. Gastroenterol. 104, 2326–2333. http://dx.doi.
org/10.1038/ajg.2009.270.
Tussing-Humphreys, L., Pusatcioglu, C., Nemeth, E., Braunschweig, C., 2012. Rethinking
iron regulation and assessment in iron deﬁciency, anemia of chronic disease, and
obesity: introducing hepcidin. J. Acad. Nutr. Diet. 112, 391–400. http://dx.doi.org/
10.1016/j.jada.2011.08.038.
Urrutia, P., Aguirre, P., Esparza, A., Tapia, V., Mena, N.P., Arredondo, M., Gonzalez-Billault,
C., Nunez, M.T., 2013. Inﬂammation alters the expression of DMT1, FPN1 and
hepcidin, and it causes iron accumulation in central nervous system cells.
J. Neurochem. 126, 541–549. http://dx.doi.org/10.1111/jnc.12244.
Valentiner-Branth, P., Steinsland, H., Santos, G., Perch, M., Begtrup, K., Bhan, M.K., Dias, F.,
Aaby, P., Sommerfelt, H., Molbak, K., 2001. Community-based controlled trial of die-
tary management of children with persistent diarrhea: sustained beneﬁcial effect
on ponderal and linear growth. Am. J. Clin. Nutr. 73, 968–974.
Victora, C.G., Adair, L., Fall, C., Hallal, P.C., Martorell, R., Richter, L., Sachdev, H.S., Maternal
& Child Undernutrition Study, G, 2008. Maternal and child undernutrition: conse-
quences for adult health and human capital. Lancet 371, 340–357. http://dx.doi.org/
10.1016/S0140-6736(07)61692-4.
Wacklin, P., Kaukinen, K., Tuovinen, E., Collin, P., Lindfors, K., Partanen, J., Maki, M., Matto,
J., 2013. The duodenal microbiota composition of adult celiac disease patients is asso-
ciated with the clinical manifestation of the disease. Inﬂamm. Bowel Dis. 19,
934–941. http://dx.doi.org/10.1097/MIB.0b013e31828029a9.
Wacklin, P., Laurikka, P., Lindfors, K., Collin, P., Salmi, T., Lahdeaho, M.L., Saavalainen, P.,
Maki, M., Matto, J., Kurppa, K., Kaukinen, K., 2014. Altered duodenal microbiota com-
position in celiac disease patients suffering from persistent symptoms on a long-term
gluten-free diet. Am. J. Gastroenterol. 109, 1933–1941. http://dx.doi.org/10.1038/ajg.
2014.355.
Wang, W., Uzzau, S., Goldblum, S.E., Fasano, A., 2000. Human zonulin, a potential modu-
lator of intestinal tight junctions. J. Cell Sci. 113 (Pt 24), 4435–4440.
Wood, G.M., Gearty, J.C., Cooper, B.T., 1991. Small bowel morphology in British Indian and
Afro-Caribbean subjects: evidence of tropical enteropathy. Gut 32, 256–259.
Yano, J.M., Yu, K., Donaldson, G.P., Shastri, G.G., Ann, P., Ma, L., Nagler, C.R., Ismagilov, R.F.,
Mazmanian, S.K., Hsiao, E.Y., 2015. Indigenous bacteria from the gut microbiota reg-
ulate host serotonin biosynthesis. Cell 161, 264–276. http://dx.doi.org/10.1016/j.cell.
2015.02.047.
Yisak, H., Gobena, T., Mesﬁn, F., 2015. Prevalence and risk factors for under nutrition
among children under ﬁve at Haramaya district, Eastern Ethiopia. BMC Pediatr. 15,
212. http://dx.doi.org/10.1186/s12887-015-0535-0.
Yu, J., Ordiz, M.I., Stauber, J., Shaikh, N., Trehan, I., Barnell, E., Head, R.D., Maleta, K., Tarr,
P.I., Manary, M.J., 2016. Environmental enteric dysfunction includes a broad spectrum
of inﬂammatory responses and epithelial repair processes. Cell. Mol. Gastroenterol.
Hepatol. 2 (158-174), e1.
